Phase I results for CPI-613 in combination with high-dose cytarabine and mitoxantrone in AML April 17, 2018
Kalytera terminates preclinical programs for synthetic endocannabinoid compounds in bone disease April 17, 2018
Stem-cell based regenerative treatment for Alzheimer's administered to first patients in Japan April 16, 2018
Telix establishes research partnership to study use of its clinical targeting agents with astatine April 16, 2018
RSS